The post US Dollar near four-week high ahead of core PCE, GDP and PMI data appeared on BitcoinEthereumNews.com. Here is what you need to know on Friday, FebruaryThe post US Dollar near four-week high ahead of core PCE, GDP and PMI data appeared on BitcoinEthereumNews.com. Here is what you need to know on Friday, February

US Dollar near four-week high ahead of core PCE, GDP and PMI data

Here is what you need to know on Friday, February 20:

The number of United States (US) citizens submitting new unemployment insurance applications decreased to 206K, much lower than initial estimates of 225K, and down from the previous week’s revised 229K, according to the US Department of Labor.

Focus now turns to US data released on Friday, including the Core Personal Consumption Expenditures (PCE) Price Index, the advance estimate for fourth-quarter US Gross Domestic Product (GDP), and preliminary February Purchasing Managers Index (PMI) data.

The US Dollar Index (DXY) trades near a four-week high of 97.90, underpinned by stronger-than-expected results from the weekly US labour market data. Investors keep digesting Wednesday’s release of the FOMC Minutes, which showed a still pretty divided Committee.

US Dollar Price Today

The table below shows the percentage change of US Dollar (USD) against listed major currencies today. US Dollar was the strongest against the Swiss Franc.

USDEURGBPJPYCADAUDNZDCHF
USD0.17%0.36%0.16%0.05%-0.06%0.00%0.37%
EUR-0.17%0.19%-0.04%-0.14%-0.23%-0.16%0.21%
GBP-0.36%-0.19%-0.21%-0.31%-0.42%-0.35%0.01%
JPY-0.16%0.04%0.21%-0.12%-0.22%-0.18%0.20%
CAD-0.05%0.14%0.31%0.12%-0.10%-0.05%0.32%
AUD0.06%0.23%0.42%0.22%0.10%0.07%0.44%
NZD-0.00%0.16%0.35%0.18%0.05%-0.07%0.37%
CHF-0.37%-0.21%-0.01%-0.20%-0.32%-0.44%-0.37%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

EUR/USD is trading near the 1.1770 price region after markets digested the news that European Central Bank (ECB) President Christine Lagarde may step down earlier than her planned retirement in October 2027.

GBP/USD is trading near the 1.3460 price region, under pressure from cooling United Kingdom (UK) inflation and job market conditions, which have weighed heavily on the British currency.

USD/JPY is trading near the 154.90 price region, trimming almost half of yesterday’s losses after resilient US economic data and a hawkish tone in the Federal Open Market Committee (FOMC) Minutes.

AUD/USD is trading near the 0.7050 price zone, losing all its momentum after having posted a three-year high last week.

USD/CAD is trading close to the 1.3700 level, maintaining a week-long rally as the Bank of Canada (BoC) adopts a dovish stance while inflationary pressure has remained close to the central bank’s 2% target.

Gold is trading at $4,982 seeing little change throughout the day as geopolitical tensions eased.

What’s next in the docket:

Friday, February 20:

  • UK January Retail Sales.
  • Germany February flash HCOB Composite PMIs.
  • Eurozone PMIs.
  • UK flash February S&P Global PMIs.
  • US December Core Personal Consumption Expenditures.
  • February US S&P Global PMIs.

Gold FAQs

Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.

Source: https://www.fxstreet.com/news/forex-today-us-dollar-near-four-week-high-ahead-of-core-pce-gdp-and-pmi-data-202602191954

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.056
$1.056$1.056
-0.35%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03